Cargando…
FDA oversight of NSIGHT genomic research: the need for an integrated systems approach to regulation
The National Institutes of Health (NIH) funded the Newborn Sequencing In Genomic medicine and public HealTh (NSIGHT) Consortium to investigate the implications, challenges, and opportunities associated with the possible use of genomic sequence information in the newborn period. Following announcemen...
Autores principales: | Milko, Laura V., Chen, Flavia, Chan, Kee, Brower, Amy M., Agrawal, Pankaj B., Beggs, Alan H., Berg, Jonathan S., Brenner, Steven E., Holm, Ingrid A., Koenig, Barbara A., Parad, Richard B., Powell, Cynthia M., Kingsmore, Stephen F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6904743/ https://www.ncbi.nlm.nih.gov/pubmed/31839987 http://dx.doi.org/10.1038/s41525-019-0105-8 |
Ejemplares similares
-
FDA oversight of medical devices
por: Hill, Matthew W, et al.
Publicado: (2012) -
Tigers, black swans, and unicorns: The need for feedback and oversight
por: Houck, Max M.
Publicado: (2019) -
The NSIGHT1-randomized controlled trial: rapid whole-genome sequencing for accelerated etiologic diagnosis in critically ill infants
por: Petrikin, Josh E., et al.
Publicado: (2018) -
Review of the Processes for FDA Oversight of Drugs, Medical Devices, and Combination Products
por: Sweet, Burgunda V., et al.
Publicado: (2011) -
COVID-19 vaccine development, production and regulatory oversight in African countries
por: Makenga, Geofrey, et al.
Publicado: (2022)